Calendar
December 1, 2022 - Erik Penser Bank Temadag - Healthcare
December 15, 2022 - DNB Nordic Healthcare Conference
February 22, 2023 - Year-end Report Q4 2022
Investors
Egetis is an innovative, unique, and integrated pharmaceutical drug development company, focusing on projects in late-stage development for treatment of serious rare/niche diseases with significant unmet medical needs in the orphan drug segment
Share
Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden
Phone: +46 8 679 72 10
E-mail: info@egetis.com
